期刊文献+

异基因造血干细胞移植后植入功能不良的危险因素分析 被引量:1

Risk factors of poor graft function after allogeneic hematopoietic stem cell transplantation
下载PDF
导出
摘要 目的探讨异基因造血干细胞移植(allo-HSCT)后植入功能不良(PGF)的危险因素。方法对2014年1月至2021年12月贵州医科大学附属医院333例行allo-HSCT的患者进行回顾性分析,将患者分为PGF组(n=32)和植入功能良好(GGF)组(n=301),通过单因素分析和logistic回归分析确定PGF可能的影响因素,并采用Kaplan-Meier生存分析对比两组患者的生存差异。结果原发疾病为急性髓系白血病(AML)、急性淋巴细胞白血病(ALL)、骨髓增生异常综合征(MDS)、重型再生障碍性贫血(SAA)及其他的患者PGF发生率分别为6.94%、3.96%、14.28%、26.23%、0,差异有统计学意义(χ^(2)=26.021,P<0.001),SAA患者PGF发生率最高。单因素logistic回归分析表明SAA患者与AML、ALL、MDS及其他患者相比,移植后更易发生PGF(OR=1.514,95%CI:1.158~1.980,P=0.002)。多因素logistic回归分析结果表明,单倍体相合移植(OR=2.585,95%CI:1.163~5.742,P=0.020)、输注CD34^(+)细胞数≤5×10^(6)/L(OR=2.330,95%CI:1.058~5.132,P=0.036)、巨细胞病毒(CMV)感染(CMV-DNA>500 copies/mL,OR=2.933,95%CI:1.292~5.623,P=0.010)是PGF的独立危险因素。Kaplan-Meier生存曲线显示,PGF组3年总生存率、3年无进展生存率均明显低于GGF组(37.5%vs.47.8%、25.0%vs.36.8%,P<0.05)。结论单倍体相合移植、输注CD34^(+)细胞数低(≤5×10^(6)/kg)、CMV感染与PGF的发生密切相关,SAA也是PGF的危险因素,SAA患者较AML、ALL、MDS患者移植后更易出现PGF。 Objective To investigate the risk factors of poor graft function(PGF)after allogeneic hematopoietic stem cell transplantation(allo-HSCT).Methods A total of 333 patients who underwent allo-HSCT from January 2014 to December 2021 in the Affiliated Hospital of Guizhou Medical University were retrospectively analyzed and divided into the PGF group(n=32)and good graft function(GGF)group(n=301).Univariate analysis and logistic regression analysis were used to determine the possible influencing factors of PGF,and the survival difference between the two groups was compared by using Kaplan-Meier survival analysis.Results The incidence of PGF in patients with primary diseases such as acute myeloid leukemia(AML),acute lymphoblastic leukemia(ALL),myelodysplastic syndrome(MDS),severe aplastic anemia(SAA)and others was 6.94%,3.96%,14.28%,26.23% and 0,respectively,the difference was statistically significant(χ^(2)=26.021,P<0.001),and the incidence of PGF was the highest in patients with SAA.The results of univariate logistic regression analysis showed that SAA patients were more likely to develop PGF after transplantation compared with AML,ALL,MDS,and other patients(OR=1.514,95%CI:1.158-1.980,P=0.002).The results of multivariate logistic regression analysis showed that haploidentical transplantation(OR=2.585,95%CI:1.163-5.742,P=0.020),infusion of CD34^(+)cell count≤5×10^(6)/kg(OR=2.330,95%CI:1.058-5.132,P=0.036)and cytomegalovirus(CMV)infection(CMV-DNA>500 copies/mL,OR=2.933,95%CI:1.292-5.623,P=0.010)were the independent risk factors for PGF.Kaplan-Meier survival curve showed that the 3-year overall survival and 3-year progression-free survival rates of the PGF group were lower than those in the GGF group(37.5%vs.47.8%,25.0%vs.36.8%,P<0.05).Conclusion Haploidentical transplantation,low number of infused CD34+cells(≤5×10^(6)/kg)and CMV infection are closely related to the occurrence of PGF.SAA is a risk factor for PGF as well,and patients with SAA are more likely to develop PGF after transplantation than patients with AML,ALL and MDS.
作者 孙水云 刘谍 夏新兰 李燕 张燕 赵鹏 李艳菊 李梦醒 王季石 卢英豪 SUN Shuiyun;LIU Die;XIA Xinlan;LI Yan;ZHANG Yan;ZHAO Peng;LI Yanju;LI Mengxing;WANG Jishi;LU Yinghao(School of Clinical Medicine,Guizhou Medical University,Guiyang,Guizhou 550004,China;Department of Hematology,The Affiliated Hospital of Guizhou Medical University/Guizhou Hematopoietic Stem Cell Transplantation Center,Guiyang,Guizhou 550004,China)
出处 《重庆医学》 CAS 2023年第20期3041-3047,共7页 Chongqing medicine
基金 国家自然科学基金项目(82060035) 贵州医科大学附属医院博士科研启动基金项目(gyfybsky-2021-13) 贵州省卫生健康委员会课题研究项目(gzwjkj2020-1-079)。
关键词 异基因造血干细胞移植 植入功能不良 危险因素 重型再生障碍性贫血 发病率 allogeneic hematopoietic stem cell transplantation poor graft function risk factors severe aplastic anemia incidence rate
  • 相关文献

参考文献5

二级参考文献21

  • 1黄晓军,江倩,陈欢,许兰平,刘代红,陈育红,韩伟,张耀臣,刘开颜,陆道培.甲氨蝶呤治疗异基因造血干细胞移植后的移植物抗宿主病[J].中华医学杂志,2005,85(16):1097-1101. 被引量:4
  • 2Nakamae H,Storer B,Sandmaier BM. Cytopenias after day 28 in allogeneic hematopoietic cell transplantation:impact of recipient/donor factors,transplant conditions and myelotoxic drugs[J].HAEMATOLOGICA,2011,(12):1838-1845.
  • 3Bruno B,Gooley T,Sullivan KM. Secondary failure of platelet recovery after hematopoietic stem cell transplantation[J].Biology of Blood and Marrow Transplantation,2001,(03):154-162.
  • 4Kong Y,Chang Y J,Wang YZ. Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation[J].Biology of Blood and Marrow Transplantation,2013,(10):1465-1473.
  • 5Dominietto A,Raiola AM,van Lint MT. Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants:graft-versus-host disease,donor type,cytomegalovirus infections and cell dose[J].British Journal of Haematology,2001,(01):219-227.
  • 6Olsson R,Remberger M,Schaffer M. Graft failure in the modem era of allogeneic hematopoietic SCT[J].Bone Marrow Transplantation,2013,(04):537-543.
  • 7Yan CH,Liu DH,Liu KY. Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation[J].Blood,2012,(14):3256-3262.
  • 8Huang XJ,Zhu HH,Chang YJ. The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate-or high-risk acute myeloid leukemia in first complete remission[J].Blood,2012,(23):5584-5590.
  • 9Thomas ED,Storb R,Cliff RA. Bone-marrow transplantation (second of two parts)[J].New England Journal of Medicine,1975,(17):895-902.
  • 10Bilgrami S,Almeida GD,Quinn JJ. Pancytopenia in allogeneic marrow transplant recipients:role of cytomegalovirus[J].British Journal of Haematology,1994,(02):357-362.

共引文献151

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部